Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04746469 · ClinicalTrials.gov registry record · NA

Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits

A NA study, sponsored by University of California, Los Angeles.

Completed
Registry status
NA
Development phase
2,500
Enrollment target

NCT04746469: Completed NA study, sponsored by University of California, Los Angeles.

NCT04746469 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 2,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04746469, a NA study, has completed, sponsored by University of California, Los Angeles.

COMPLETED
Registry status
NA
Development phase
2,500 participants
Enrollment target

Study Summary

As a part of UCLA Health's continued goal of improving patient care the investigators are updating our mailing campaign for our FIT Kit colorectal cancer screening that the investigators administer 2 times per year to include an automated phone call reminder to patients who are overdue for average-risk colorectal cancer screening and enrolled in a mailed FIT program. This will help the investigators evaluate if automated phone calls are effective at improving compliance with CRC screening, in addition to mailed FIT and embedded electronic health record (EHR) portal messages to patients.

Primary Outcome

Rate of completion of CRC screening by any of the following: FIT, colonoscopy, CT colonography, sigmoidoscopy or FIT-DNA within study period.

Interventions

  • BEHAVIORAL Delayed automated phone call

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2020-09-02
Est. Completion 2022-08-01
Phase NA

What the finished NCT04746469 record still lists

NCT04746469 is an interventional study that assigns participants to a tested intervention. Its 2,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% higher).

The record links to 0 conditions, and to 1 intervention - of which Delayed automated phone call is the first listed.

NCT04746469 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04746469 about?

NCT04746469 is a clinical study titled "Using Behavioral Science to Improve Colorectal Cancer Screening Rates With Mailed FIT Kits". As a part of UCLA Health's continued goal of improving patient care the investigators are updating our mailing campaign for our FIT Kit colorectal cancer screening that the investigators administer 2 times per year to include an automated phone call reminder to patients who are overdue for average-r...

What is the current status of trial NCT04746469?

This trial is currently completed. It is a NA study. The enrollment target is 2,500 participants. The study started on 2020-09-02. Estimated completion is 2022-08-01.

What interventions are being tested in trial NCT04746469?

The interventions under investigation include: Delayed automated phone call (BEHAVIORAL).

Who is sponsoring clinical trial NCT04746469?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04746469's enrollment target sits among peer trials

2,500 44th of 2000 higher than 1,956 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001160 · 2,500 participants

    Studies on Tumors of the Thyroid

  • NCT01904188 · 2,500 participants

    Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?

  • NCT02257229 · 2,500 participants

    Prospective Evaluation of Treatment for Clubfoot

  • NCT02530658 · 2,500 participants

    Next Generation Sequencing of Normal Tissues Prospectively in Pediatric Oncology Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04746469, the US trial registry maintained by the National Library of Medicine. NCT04746469 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.